Octreotide and ketoconazole for persistent ectopic ACTH Cushing's disease due to mediastinal carcinoid.
dc.contributor.author | Parthiban, A | en_US |
dc.contributor.author | Sundaram, D S | en_US |
dc.contributor.author | Reddy, D J | en_US |
dc.contributor.author | Girinath, M R | en_US |
dc.contributor.author | Prabhakaran, R | en_US |
dc.contributor.author | Chidambaranathan, N | en_US |
dc.date.accessioned | 1995-02-01 | en_US |
dc.date.accessioned | 2009-05-31T00:27:03Z | |
dc.date.available | 1995-02-01 | en_US |
dc.date.available | 2009-05-31T00:27:03Z | |
dc.date.issued | 1995-02-01 | en_US |
dc.description.affiliation | Apollo Hospital, Madras, Tamil Nadu. | en_US |
dc.identifier.citation | Parthiban A, Sundaram DS, Reddy DJ, Girinath MR, Prabhakaran R, Chidambaranathan N. Octreotide and ketoconazole for persistent ectopic ACTH Cushing's disease due to mediastinal carcinoid. Journal of the Association of Physicians of India. 1995 Feb; 43(2): 140 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/91318 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Adrenocorticotropic Hormone --blood | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antineoplastic Agents, Hormonal --therapeutic use | en_US |
dc.subject.mesh | Carcinoid Tumor --complications | en_US |
dc.subject.mesh | Chemotherapy, Adjuvant | en_US |
dc.subject.mesh | Cushing Syndrome --blood | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Ketoconazole --therapeutic use | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mediastinal Neoplasms --complications | en_US |
dc.subject.mesh | Octreotide --therapeutic use | en_US |
dc.title | Octreotide and ketoconazole for persistent ectopic ACTH Cushing's disease due to mediastinal carcinoid. | en_US |
dc.type | Case Reports | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1